- HCA Healthcare Inc (NYSE:HCA) has reported Q1 FY23 revenues of $15.59 billion, compared to $14.94 billion a year ago, missing the consensus of $15.27 billion.
- EPS of $4.93 was higher than the $4.12 reported a year ago, surpassing the estimate of $3.93.
- Same-facility admissions increased by 4.4% Y/Y, and equivalent admissions increased by 7.5%.
- HCA’s inpatient surgery cases increased by 2.8%, and outpatient surgery cases climbed by 3.5%.
- COVID-19 represented 3.1% of same-facility admissions in the first quarter of 2023 versus 9.7% a year ago.
- Also Read: Hospital Facilities To Face Slower Earnings Growth In 2023, Analyst Says While Initiating Coverage On Two Large Stocks.
- HCA saw a moderation of its staffing costs, with salaries and benefits expenses accounting for 45.4% of its revenue versus 46.4% a year ago.
- For Q1 2023, Adjusted EBITDA totaled $3.172 billion, compared to $2.944 billion in the first quarter of 2022.
- Cash flows from operating activities totaled $1.8 billion.
- Outlook: For FY23, HCA Healthcare raised revenues guidance to $62.5-$64.5 billion from $61.5-63.5 billion compared to the consensus Of $62.61 billion.
- The company forecasts EPS Of $17.25-$18.55, up from $16.40-$17.60 versus the consensus of $17.25.
- Price Action: HCA shares are up 5.31% at $285.15 during the premarket session on the last check Friday.
Tempur Sealy Board Extends CEO Scott Thompson’s Employment Contract to December 31, 2026
Tempur Sealy International, Inc. (NYSE: TPX, "Company" or "Tempur Sealy") today announced that the Board of Directors has extended the term of Scott Thompson's employment contract as Chairman, Chief Executive Officer and President of the Company to December 31, 2026. Mr. Thompson has been Chairman, Chief Executive Officer and President since September 2015.
